- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
An anonymous representative alleged pressure to promote Aldara off-licence and raised concerns about call-rate targets and a GP…
Novartis’ UK press release headline implied an overall survival benefit for Femara vs tamoxifen despite non-significant ITT results…
Allergan’s Botox monograph made comparative claims vs Dysport (and referenced Xeomin). Panel found several claims misleading/unsubstantiated and ruled…
A trust clinical director alleged a Pfizer rep was intimidating and applied inappropriate pressure when trying to access…
Cephalon’s internal congress feedback note described “clubbing” and late-night bars with HCPs and urged “lets make sure they…
A Protopic leavepiece themed around “a whole British summer” was ruled inconsistent with the SPC warning to minimise…
Anonymous employee alleged Palexia mailings were triggered after every sales call, risking >8 mailings/year. Panel found mailer was…
A GP complained about a Flutiform promotional email sent to an NHS address via a third-party agency. The…
PMCPA found Bayer’s Xarelto conference panel and booklet claims overstated day-one “protection” and implied proven compliance advantages. Missing…
Anonymous HCP challenged Seretide promotion using TORCH secondary endpoints despite non-significant primary endpoint (p=0.052). PMCPA found some materials…
One real case. One key lesson. Every week — free.